ReP USP - Resultado da busca

Artigo de periodico
Association of the genetic ancestry with resistant hypertension in the ReHOT (Resistant Hypertension Optimal Treatment) randomized study (2020)
Bueno, Carolina Tosin; Pereira, Alexandre Costa; Santos, Hadassa Campos; Gomez, Luz Marina Gomez; Horimoto, Andrea Roseli Vancan Russo; Krieger, Eduardo Moacyr; Krieger, Jose Eduardo ; Santos, Paulo Caleb Junior Lima
Source: Scientific reports. Unidade: FM
Subjects: HIPERTENSÃO, ÍNDIOS, MEIA IDADE, POLIMORFISMO, ESTUDOS PROSPECTIVOS, AFRICANOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BUENO, Carolina Tosin et al. Association of the genetic ancestry with resistant hypertension in the ReHOT (Resistant Hypertension Optimal Treatment) randomized study. Scientific reports, v. 10, n. 1, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41598-020-58540-3. Acesso em: 06 nov. 2024.
APA
Bueno, C. T., Pereira, A. C., Santos, H. C., Gomez, L. M. G., Horimoto, A. R. V. R., Krieger, E. M., et al. (2020). Association of the genetic ancestry with resistant hypertension in the ReHOT (Resistant Hypertension Optimal Treatment) randomized study. Scientific reports, 10( 1). doi:10.1038/s41598-020-58540-3
NLM
Bueno CT, Pereira AC, Santos HC, Gomez LMG, Horimoto ARVR, Krieger EM, Krieger JE, Santos PCJL. Association of the genetic ancestry with resistant hypertension in the ReHOT (Resistant Hypertension Optimal Treatment) randomized study [Internet]. Scientific reports. 2020 ; 10( 1):[citado 2024 nov. 06 ] Available from: https://doi.org/10.1038/s41598-020-58540-3
Vancouver
Bueno CT, Pereira AC, Santos HC, Gomez LMG, Horimoto ARVR, Krieger EM, Krieger JE, Santos PCJL. Association of the genetic ancestry with resistant hypertension in the ReHOT (Resistant Hypertension Optimal Treatment) randomized study [Internet]. Scientific reports. 2020 ; 10( 1):[citado 2024 nov. 06 ] Available from: https://doi.org/10.1038/s41598-020-58540-3
Artigo de periodico
Cytochrome P450 2A6 and 2B6 polymorphisms and smoking cessation success in patients treated with varenicline (2019)
Tomaz, Paulo Roberto Xavier; Kajita, Mariana Soares; Santos, Juliana Rocha; Scholz, Jaqueline; Abe, Tania Ogawa; Gaya, Patricia Viviane; Krieger, José Eduardo ; Pereira, Alexandre Costa; Santos, Paulo Caleb Junior Lima
Source: European journal of clinical pharmacology. Unidade: FM
Subjects: POLIMORFISMO, FÁRMACOS (SISTEMA NERVOSO PERIFÉRICO), TABAGISMO, CITOCROMO P-450, GENÓTIPOS, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOMAZ, Paulo Roberto Xavier et al. Cytochrome P450 2A6 and 2B6 polymorphisms and smoking cessation success in patients treated with varenicline. European journal of clinical pharmacology, v. 75, n. 11, p. 1541-1545, 2019Tradução . . Disponível em: https://doi.org/10.1007/s00228-019-02731-z. Acesso em: 06 nov. 2024.
APA
Tomaz, P. R. X., Kajita, M. S., Santos, J. R., Scholz, J., Abe, T. O., Gaya, P. V., et al. (2019). Cytochrome P450 2A6 and 2B6 polymorphisms and smoking cessation success in patients treated with varenicline. European journal of clinical pharmacology, 75( 11), 1541-1545. doi:10.1007/s00228-019-02731-z
NLM
Tomaz PRX, Kajita MS, Santos JR, Scholz J, Abe TO, Gaya PV, Krieger JE, Pereira AC, Santos PCJL. Cytochrome P450 2A6 and 2B6 polymorphisms and smoking cessation success in patients treated with varenicline [Internet]. European journal of clinical pharmacology. 2019 ; 75( 11): 1541-1545.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s00228-019-02731-z
Vancouver
Tomaz PRX, Kajita MS, Santos JR, Scholz J, Abe TO, Gaya PV, Krieger JE, Pereira AC, Santos PCJL. Cytochrome P450 2A6 and 2B6 polymorphisms and smoking cessation success in patients treated with varenicline [Internet]. European journal of clinical pharmacology. 2019 ; 75( 11): 1541-1545.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s00228-019-02731-z
Artigo de periodico
Quality of life scores differs between genotypic groups of patients with suspected hereditary hemochromatosis (2018)
Fonseca, Paula Fernanda Silva; Cancado, Rodolfo Delfini; Naoum, Flavio Augusto; Dinardo, Carla Luana; Fonseca, Guilherme Henrique Hencklain; Gualandro, Sandra Fatima Menosi; Krieger, Jose Eduardo; Pereira, Alexandre Costa; Brissot, Pierre; Santos, Paulo Caleb Junior Lima
Source: Bmc medical genetics. Unidade: FM
Subjects: HEMOCROMATOSE, QUALIDADE DE VIDA, QUESTIONÁRIOS, GENÓTIPOS, DOENÇAS GENÉTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FONSECA, Paula Fernanda Silva et al. Quality of life scores differs between genotypic groups of patients with suspected hereditary hemochromatosis. Bmc medical genetics, v. 19, 2018Tradução . . Disponível em: https://doi.org/10.1186/s12881-017-0513-5. Acesso em: 06 nov. 2024.
APA
Fonseca, P. F. S., Cancado, R. D., Naoum, F. A., Dinardo, C. L., Fonseca, G. H. H., Gualandro, S. F. M., et al. (2018). Quality of life scores differs between genotypic groups of patients with suspected hereditary hemochromatosis. Bmc medical genetics, 19. doi:10.1186/s12881-017-0513-5
NLM
Fonseca PFS, Cancado RD, Naoum FA, Dinardo CL, Fonseca GHH, Gualandro SFM, Krieger JE, Pereira AC, Brissot P, Santos PCJL. Quality of life scores differs between genotypic groups of patients with suspected hereditary hemochromatosis [Internet]. Bmc medical genetics. 2018 ; 19[citado 2024 nov. 06 ] Available from: https://doi.org/10.1186/s12881-017-0513-5
Vancouver
Fonseca PFS, Cancado RD, Naoum FA, Dinardo CL, Fonseca GHH, Gualandro SFM, Krieger JE, Pereira AC, Brissot P, Santos PCJL. Quality of life scores differs between genotypic groups of patients with suspected hereditary hemochromatosis [Internet]. Bmc medical genetics. 2018 ; 19[citado 2024 nov. 06 ] Available from: https://doi.org/10.1186/s12881-017-0513-5
Artigo de periodico
Impact of incorporating ABCB1 and CYP4F2 polymorphisms in a pharmacogenetics-guided warfarin dosing algorithm for the Brazilian population (2018)
Tavares, Leticia C.; Duarte, Nubia E; Marcatto, Leiliane R; Soares, Renata A. G; Krieger, José Eduardo; Pereira, Alexandre C; Santos, Paulo Caleb Junior Lima
Source: European journal of clinical pharmacology. Unidade: FM
Subjects: POLIMORFISMO, ANTICOAGULANTES, ALGORITMOS GENÉTICOS, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAVARES, Leticia C. et al. Impact of incorporating ABCB1 and CYP4F2 polymorphisms in a pharmacogenetics-guided warfarin dosing algorithm for the Brazilian population. European journal of clinical pharmacology, v. 74, n. 12, p. 1555-1566, 2018Tradução . . Disponível em: https://doi.org/10.1007/s00228-018-2528-z. Acesso em: 06 nov. 2024.
APA
Tavares, L. C., Duarte, N. E., Marcatto, L. R., Soares, R. A. G., Krieger, J. E., Pereira, A. C., & Santos, P. C. J. L. (2018). Impact of incorporating ABCB1 and CYP4F2 polymorphisms in a pharmacogenetics-guided warfarin dosing algorithm for the Brazilian population. European journal of clinical pharmacology, 74( 12), 1555-1566. doi:10.1007/s00228-018-2528-z
NLM
Tavares LC, Duarte NE, Marcatto LR, Soares RAG, Krieger JE, Pereira AC, Santos PCJL. Impact of incorporating ABCB1 and CYP4F2 polymorphisms in a pharmacogenetics-guided warfarin dosing algorithm for the Brazilian population [Internet]. European journal of clinical pharmacology. 2018 ; 74( 12): 1555-1566.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s00228-018-2528-z
Vancouver
Tavares LC, Duarte NE, Marcatto LR, Soares RAG, Krieger JE, Pereira AC, Santos PCJL. Impact of incorporating ABCB1 and CYP4F2 polymorphisms in a pharmacogenetics-guided warfarin dosing algorithm for the Brazilian population [Internet]. European journal of clinical pharmacology. 2018 ; 74( 12): 1555-1566.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s00228-018-2528-z
Artigo de periodico
Age is associated with time in therapeutic range for warfarin therapy in patients with atrial fibrillation (2016)
Marcatto, Leiliane Rodrigues; Sacilotto, Luciana; Darrieux, Francisco Carlos da Costa; Hachul, Denise Tessariol; Scanavacca, Maurício Ibrahim; Krieger, Jose Eduardo; Pereira, Alexandre Costa; Santos, Paulo Caleb Junior Lima
Source: OncoTarget. Unidade: FM
Subjects: REGRESSÃO LINEAR, ESTUDOS RETROSPECTIVOS, FIBRILAÇÃO ATRIAL, FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARCATTO, Leiliane Rodrigues et al. Age is associated with time in therapeutic range for warfarin therapy in patients with atrial fibrillation. OncoTarget, v. 7, n. 34, p. 54194-54199, 2016Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.10944. Acesso em: 06 nov. 2024.
APA
Marcatto, L. R., Sacilotto, L., Darrieux, F. C. da C., Hachul, D. T., Scanavacca, M. I., Krieger, J. E., et al. (2016). Age is associated with time in therapeutic range for warfarin therapy in patients with atrial fibrillation. OncoTarget, 7( 34), 54194-54199. doi:10.18632/oncotarget.10944
NLM
Marcatto LR, Sacilotto L, Darrieux FC da C, Hachul DT, Scanavacca MI, Krieger JE, Pereira AC, Santos PCJL. Age is associated with time in therapeutic range for warfarin therapy in patients with atrial fibrillation [Internet]. OncoTarget. 2016 ; 7( 34): 54194-54199.[citado 2024 nov. 06 ] Available from: https://doi.org/10.18632/oncotarget.10944
Vancouver
Marcatto LR, Sacilotto L, Darrieux FC da C, Hachul DT, Scanavacca MI, Krieger JE, Pereira AC, Santos PCJL. Age is associated with time in therapeutic range for warfarin therapy in patients with atrial fibrillation [Internet]. OncoTarget. 2016 ; 7( 34): 54194-54199.[citado 2024 nov. 06 ] Available from: https://doi.org/10.18632/oncotarget.10944
Artigo de periodico
Development of a pharmacogenetic-based warfarin dosing algorithm and its performance in Brazilian patients: highlighting the importance of population-specific calibration (2015)
Santos, Paulo Caleb Junior Lima; Marcatto, Leiliane Rodrigues; Duarte, Nubia Esteban; Soares, Renata Alonso Gadi; Strunz, Celia Maria Cassaro; Scanavacca, Maurício; Krieger, Jose Eduardo; Pereira, Alexandre Costa
Source: Pharmacogenomics. Unidade: FM
Subjects: TROMBOSE, BRASILEIROS, ALGORITMOS ÚTEIS E ESPECÍFICOS, FARMACOGENÉTICA (TENDÊNCIAS), ANTICOAGULANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Paulo Caleb Junior Lima et al. Development of a pharmacogenetic-based warfarin dosing algorithm and its performance in Brazilian patients: highlighting the importance of population-specific calibration. Pharmacogenomics, v. 16, n. 8, p. 865-876, 2015Tradução . . Disponível em: http://www.futuremedicine.com/doi/pdf/10.2217/pgs.15.48. Acesso em: 06 nov. 2024.
APA
Santos, P. C. J. L., Marcatto, L. R., Duarte, N. E., Soares, R. A. G., Strunz, C. M. C., Scanavacca, M., et al. (2015). Development of a pharmacogenetic-based warfarin dosing algorithm and its performance in Brazilian patients: highlighting the importance of population-specific calibration. Pharmacogenomics, 16( 8), 865-876. doi:10.2217/PGS.15.48
NLM
Santos PCJL, Marcatto LR, Duarte NE, Soares RAG, Strunz CMC, Scanavacca M, Krieger JE, Pereira AC. Development of a pharmacogenetic-based warfarin dosing algorithm and its performance in Brazilian patients: highlighting the importance of population-specific calibration [Internet]. Pharmacogenomics. 2015 ; 16( 8): 865-876.[citado 2024 nov. 06 ] Available from: http://www.futuremedicine.com/doi/pdf/10.2217/pgs.15.48
Vancouver
Santos PCJL, Marcatto LR, Duarte NE, Soares RAG, Strunz CMC, Scanavacca M, Krieger JE, Pereira AC. Development of a pharmacogenetic-based warfarin dosing algorithm and its performance in Brazilian patients: highlighting the importance of population-specific calibration [Internet]. Pharmacogenomics. 2015 ; 16( 8): 865-876.[citado 2024 nov. 06 ] Available from: http://www.futuremedicine.com/doi/pdf/10.2217/pgs.15.48
Artigo de periodico
Presence and type of low density lipoprotein receptor (LDLR) mutation influences the lipid profile and response to lipid-lowering therapy in Brazilian patients with heterozygous familial hypercholesterolemia (2014)
Santos, Paulo Caleb Junior Lima; Morgan, Aline Cruz; Jannes, Cintia Elin; Turolla, Luciana; Krieger, Jose Eduardo; Santos, Raul D.; Pereira, Alexandre Costa
Source: Atherosclerosis. Unidade: FM
Subjects: MUTAÇÃO GENÉTICA, BRASILEIROS, EXPRESSÃO GÊNICA, LIPÍDEOS (TERAPIA), HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Paulo Caleb Junior Lima et al. Presence and type of low density lipoprotein receptor (LDLR) mutation influences the lipid profile and response to lipid-lowering therapy in Brazilian patients with heterozygous familial hypercholesterolemia. Atherosclerosis, v. 233, n. 1, p. 206-210, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2013.12.028. Acesso em: 06 nov. 2024.
APA
Santos, P. C. J. L., Morgan, A. C., Jannes, C. E., Turolla, L., Krieger, J. E., Santos, R. D., & Pereira, A. C. (2014). Presence and type of low density lipoprotein receptor (LDLR) mutation influences the lipid profile and response to lipid-lowering therapy in Brazilian patients with heterozygous familial hypercholesterolemia. Atherosclerosis, 233( 1), 206-210. doi:10.1016/j.atherosclerosis.2013.12.028
NLM
Santos PCJL, Morgan AC, Jannes CE, Turolla L, Krieger JE, Santos RD, Pereira AC. Presence and type of low density lipoprotein receptor (LDLR) mutation influences the lipid profile and response to lipid-lowering therapy in Brazilian patients with heterozygous familial hypercholesterolemia [Internet]. Atherosclerosis. 2014 ; 233( 1): 206-210.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2013.12.028
Vancouver
Santos PCJL, Morgan AC, Jannes CE, Turolla L, Krieger JE, Santos RD, Pereira AC. Presence and type of low density lipoprotein receptor (LDLR) mutation influences the lipid profile and response to lipid-lowering therapy in Brazilian patients with heterozygous familial hypercholesterolemia [Internet]. Atherosclerosis. 2014 ; 233( 1): 206-210.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2013.12.028
Artigo de periodico
ACTN3 R577X polymorphism and long-term survival in patients with chronic heart failure (2014)
Bernardez-Pereira, Sabrina; Santos, Paulo Caleb Junior Lima; Krieger, Jose Eduardo; Mansur, Alfredo Jose; Pereira, Alexandre Costa
Source: BMC cardiovascular disorders. Unidade: FM
Subjects: PROGNÓSTICO, INSUFICIÊNCIA CARDÍACA (ETIOLOGIA), POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BERNARDEZ-PEREIRA, Sabrina et al. ACTN3 R577X polymorphism and long-term survival in patients with chronic heart failure. BMC cardiovascular disorders, v. 14, n. 90, p. 5 2014, 2014Tradução . . Disponível em: https://doi.org/10.1186/1471-2261-14-90. Acesso em: 06 nov. 2024.
APA
Bernardez-Pereira, S., Santos, P. C. J. L., Krieger, J. E., Mansur, A. J., & Pereira, A. C. (2014). ACTN3 R577X polymorphism and long-term survival in patients with chronic heart failure. BMC cardiovascular disorders, 14( 90), 5 2014. doi:10.1186/1471-2261-14-90
NLM
Bernardez-Pereira S, Santos PCJL, Krieger JE, Mansur AJ, Pereira AC. ACTN3 R577X polymorphism and long-term survival in patients with chronic heart failure [Internet]. BMC cardiovascular disorders. 2014 ; 14( 90): 5 2014.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1186/1471-2261-14-90
Vancouver
Bernardez-Pereira S, Santos PCJL, Krieger JE, Mansur AJ, Pereira AC. ACTN3 R577X polymorphism and long-term survival in patients with chronic heart failure [Internet]. BMC cardiovascular disorders. 2014 ; 14( 90): 5 2014.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1186/1471-2261-14-90
Artigo de periodico
Simultaneous Use of Amiodarone Influences Warfarin Maintenance Dose but Is Not Associated with Adverse Events (2014)
Santos, Paulo Caleb Junior Lima; Soares, Renata Alonso Gadi; Strunz, Celia Maria Cassaro; Grinberg, Max; Ferreira, João Fernando M.; Cesar, Luiz Antônio Machado; Scanavacca, Maurício; krieger, Jose Eduardo; Pereira Alexandre Costa
Source: Journal of managed care pharmacy. Unidade: FM
Subjects: INTERAÇÃO DE MEDICAMENTOS (MONITORAMENTO;EFEITOS ADVERSOS), DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Paulo Caleb Junior Lima et al. Simultaneous Use of Amiodarone Influences Warfarin Maintenance Dose but Is Not Associated with Adverse Events. Journal of managed care pharmacy, v. 20, n. 4, p. 376-381, 2014Tradução . . Disponível em: https://doi.org/10.18553/jmcp.2014.20.4.376. Acesso em: 06 nov. 2024.
APA
Santos, P. C. J. L., Soares, R. A. G., Strunz, C. M. C., Grinberg, M., Ferreira, J. F. M., Cesar, L. A. M., et al. (2014). Simultaneous Use of Amiodarone Influences Warfarin Maintenance Dose but Is Not Associated with Adverse Events. Journal of managed care pharmacy, 20( 4), 376-381. doi:10.18553/jmcp.2014.20.4.376
NLM
Santos PCJL, Soares RAG, Strunz CMC, Grinberg M, Ferreira JFM, Cesar LAM, Scanavacca M, krieger JE, Pereira Alexandre Costa. Simultaneous Use of Amiodarone Influences Warfarin Maintenance Dose but Is Not Associated with Adverse Events [Internet]. Journal of managed care pharmacy. 2014 ; 20( 4): 376-381.[citado 2024 nov. 06 ] Available from: https://doi.org/10.18553/jmcp.2014.20.4.376
Vancouver
Santos PCJL, Soares RAG, Strunz CMC, Grinberg M, Ferreira JFM, Cesar LAM, Scanavacca M, krieger JE, Pereira Alexandre Costa. Simultaneous Use of Amiodarone Influences Warfarin Maintenance Dose but Is Not Associated with Adverse Events [Internet]. Journal of managed care pharmacy. 2014 ; 20( 4): 376-381.[citado 2024 nov. 06 ] Available from: https://doi.org/10.18553/jmcp.2014.20.4.376
Artigo de periodico
CYP2C9 and VKORC1 polymorphisms influence warfarin dose variability in patients on long-term anticoagulation (2013)
Santos, Paulo Caleb Junior Lima; Dinardo, Carla Luana; Schettert, Isolmar Tadeu; Soares, Renata Alonso Gadi; Kawabata-Yoshihara, Liz; Benseñor, Isabela Martins; Krieger, José Eduardo; Lotufo, Paulo Andrade; Pereira, Alexandre Costa
Source: European Journal of Clinical Pharmacology. Unidades: FM, HU
Subjects: POLIMORFISMO, ANTICOAGULANTES (FARMACOLOGIA), FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Paulo Caleb Junior Lima et al. CYP2C9 and VKORC1 polymorphisms influence warfarin dose variability in patients on long-term anticoagulation. European Journal of Clinical Pharmacology, v. 69, n. 4, p. 789-797, 2013Tradução . . Disponível em: https://doi.org/10.1007%2Fs00228-012-1404-5. Acesso em: 06 nov. 2024.
APA
Santos, P. C. J. L., Dinardo, C. L., Schettert, I. T., Soares, R. A. G., Kawabata-Yoshihara, L., Benseñor, I. M., et al. (2013). CYP2C9 and VKORC1 polymorphisms influence warfarin dose variability in patients on long-term anticoagulation. European Journal of Clinical Pharmacology, 69( 4), 789-797. doi:10.1007%2Fs00228-012-1404-5
NLM
Santos PCJL, Dinardo CL, Schettert IT, Soares RAG, Kawabata-Yoshihara L, Benseñor IM, Krieger JE, Lotufo PA, Pereira AC. CYP2C9 and VKORC1 polymorphisms influence warfarin dose variability in patients on long-term anticoagulation [Internet]. European Journal of Clinical Pharmacology. 2013 ; 69( 4): 789-797.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007%2Fs00228-012-1404-5
Vancouver
Santos PCJL, Dinardo CL, Schettert IT, Soares RAG, Kawabata-Yoshihara L, Benseñor IM, Krieger JE, Lotufo PA, Pereira AC. CYP2C9 and VKORC1 polymorphisms influence warfarin dose variability in patients on long-term anticoagulation [Internet]. European Journal of Clinical Pharmacology. 2013 ; 69( 4): 789-797.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007%2Fs00228-012-1404-5
Artigo de periodico
Impact of diabetes mellitus on arterial stiffness in a representative sample of an urban Brazilian population (2013)
Alvim, Rafael de Oliveira; Santos, Paulo Caleb Junior Lima; Musso, Mariane Manso; Cunha, Roberto de Sá; Krieger, José Eduardo; Mill, José Geraldo; Pereira, Alexandre Costa
Source: Diabetology and Metabolic Syndrome. Unidade: FM
Subjects: DIABETES MELLITUS (IMPACTO), ZONA URBANA, DOENÇAS CARDIOVASCULARES (PREVENÇÃO E CONTROLE), HIPERTENSÃO (EPIDEMIOLOGIA), FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVIM, Rafael de Oliveira et al. Impact of diabetes mellitus on arterial stiffness in a representative sample of an urban Brazilian population. Diabetology and Metabolic Syndrome, v. 5, n. 45, p. 8 (online), 2013Tradução . . Disponível em: https://doi.org/10.1186/1758-5996-5-45. Acesso em: 06 nov. 2024.
APA
Alvim, R. de O., Santos, P. C. J. L., Musso, M. M., Cunha, R. de S., Krieger, J. E., Mill, J. G., & Pereira, A. C. (2013). Impact of diabetes mellitus on arterial stiffness in a representative sample of an urban Brazilian population. Diabetology and Metabolic Syndrome, 5( 45), 8 (online). doi:10.1186/1758-5996-5-45
NLM
Alvim R de O, Santos PCJL, Musso MM, Cunha R de S, Krieger JE, Mill JG, Pereira AC. Impact of diabetes mellitus on arterial stiffness in a representative sample of an urban Brazilian population [Internet]. Diabetology and Metabolic Syndrome. 2013 ; 5( 45): 8 (online).[citado 2024 nov. 06 ] Available from: https://doi.org/10.1186/1758-5996-5-45
Vancouver
Alvim R de O, Santos PCJL, Musso MM, Cunha R de S, Krieger JE, Mill JG, Pereira AC. Impact of diabetes mellitus on arterial stiffness in a representative sample of an urban Brazilian population [Internet]. Diabetology and Metabolic Syndrome. 2013 ; 5( 45): 8 (online).[citado 2024 nov. 06 ] Available from: https://doi.org/10.1186/1758-5996-5-45
Artigo de periodico
Association between the C242T polymorphism in the p22phox gene with arterial stiffness in the Brazilian population (2012)
Alvim, Rafael de Oliveira; Santos, Paulo Caleb Junior Lima; Dias, Rodrigo Gonçalves; Rodrigues, Mariliza Velho; Cunha, Roberto de Sa; Mill, José Geraldo; Nadruz Junior, Wilson; Krieger, José Eduardo; Pereira, Alexandre Costa
Source: Physiological genomics. Unidade: FM
Subjects: POLIMORFISMO, MARCADOR MOLECULAR, FENÓTIPOS, PULSO, CORONARIOPATIA, FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVIM, Rafael de Oliveira et al. Association between the C242T polymorphism in the p22phox gene with arterial stiffness in the Brazilian population. Physiological genomics, v. 44, n. 10, p. 587-592, 2012Tradução . . Disponível em: https://doi.org/10.1152/physiolgenomics.00122.2011. Acesso em: 06 nov. 2024.
APA
Alvim, R. de O., Santos, P. C. J. L., Dias, R. G., Rodrigues, M. V., Cunha, R. de S., Mill, J. G., et al. (2012). Association between the C242T polymorphism in the p22phox gene with arterial stiffness in the Brazilian population. Physiological genomics, 44( 10), 587-592. doi:10.1152/physiolgenomics.00122.2011
NLM
Alvim R de O, Santos PCJL, Dias RG, Rodrigues MV, Cunha R de S, Mill JG, Nadruz Junior W, Krieger JE, Pereira AC. Association between the C242T polymorphism in the p22phox gene with arterial stiffness in the Brazilian population [Internet]. Physiological genomics. 2012 ; 44( 10): 587-592.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1152/physiolgenomics.00122.2011
Vancouver
Alvim R de O, Santos PCJL, Dias RG, Rodrigues MV, Cunha R de S, Mill JG, Nadruz Junior W, Krieger JE, Pereira AC. Association between the C242T polymorphism in the p22phox gene with arterial stiffness in the Brazilian population [Internet]. Physiological genomics. 2012 ; 44( 10): 587-592.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1152/physiolgenomics.00122.2011
Artigo de periodico
SLCO1B1 haplotypes are not associated with atorvastatin-induced myalgia in Brazilian patients with familial hypercholesterolemia (2012)
Santos, Paulo Caleb Junior Lima; Gagliardi, Ana Carolina Moron; Miname, Márcio Hiroshi; Chacra, Ana Paula; Santos, Raul Dias; Krieger, Jose Eduardo; Pereira, Alexandre Costa
Source: European Journal of Clinical Pharmacology. Unidade: FM
Subjects: DOR (INDUZIDO QUIMICAMENTE), GENÓTIPOS, HIPERCOLESTEROLEMIA (TERAPIA;EPIDEMIOLOGIA), ANTILIPÊMICOS, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Paulo Caleb Junior Lima et al. SLCO1B1 haplotypes are not associated with atorvastatin-induced myalgia in Brazilian patients with familial hypercholesterolemia. European Journal of Clinical Pharmacology, v. 68, n. 3, p. 273-279, 2012Tradução . . Disponível em: https://doi.org/10.1007/s00228-011-1125-1. Acesso em: 06 nov. 2024.
APA
Santos, P. C. J. L., Gagliardi, A. C. M., Miname, M. H., Chacra, A. P., Santos, R. D., Krieger, J. E., & Pereira, A. C. (2012). SLCO1B1 haplotypes are not associated with atorvastatin-induced myalgia in Brazilian patients with familial hypercholesterolemia. European Journal of Clinical Pharmacology, 68( 3), 273-279. doi:10.1007/s00228-011-1125-1
NLM
Santos PCJL, Gagliardi ACM, Miname MH, Chacra AP, Santos RD, Krieger JE, Pereira AC. SLCO1B1 haplotypes are not associated with atorvastatin-induced myalgia in Brazilian patients with familial hypercholesterolemia [Internet]. European Journal of Clinical Pharmacology. 2012 ; 68( 3): 273-279.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s00228-011-1125-1
Vancouver
Santos PCJL, Gagliardi ACM, Miname MH, Chacra AP, Santos RD, Krieger JE, Pereira AC. SLCO1B1 haplotypes are not associated with atorvastatin-induced myalgia in Brazilian patients with familial hypercholesterolemia [Internet]. European Journal of Clinical Pharmacology. 2012 ; 68( 3): 273-279.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s00228-011-1125-1

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Date published

Subjects

Source title

Funding Agencies

Indexado em